Toronto, ON, March 16, 2015 /PRNewswire/ -- Axxess Pharma Inc.
(OTC: AXXE) a specialty pharmaceutical and nutritional supplements
company, through its wholly owned subsidiary, AllStar Health Brands
Inc., is pleased to announce they have now received FDA approval
from the United States to sell
their high potency Omega-3 fish oil, Muscle Growth, Muscle Recovery
supplements and Turbo Blend Protein Powders. The recent FDA
approval comes less than two weeks after Axxess Pharma's successful
meetings with two of the United
States largest distributors.
Axxess's FDA approval will not only allow this new line of
products to be distributed nationally into big box retail chain
stores, but will also facilitate entry into more regulated markets
such as Mexico and other foreign
jurisdictions. Axxess expects the latest FDA approval to accelerate
the pace of current overseas sales. Management is now projecting,
year over year sales from March 2015
to March 2016 of $2.5 million.
Dr. Daniel Bagi, President of
Axxess Pharma, Inc. stated: "We are very excited to receive FDA
approval to sell our latest line of all-natural TapouT supplements
and protein powders within the US. Our all-natural products will be
sold under the globally recognized name TapouT, and will have the
words 'FDA Approved' on every label. Our unique high potency
Omega-3 fish oil supplements is anticipated to be one of our top
sellers both in the US and internationally."
Dr. Fred Maese, Senior
Consultant of Medical Affairs for Axxess Pharma, Inc. stated:
"More than 100 million Americans are at risk for cardiovascular
disease, hypertension, stroke, diabetes, obesity, elevated
triglycerides, mood disorders, osteoarthritis and premature aging.
I strongly recommend a healthy lifestyle and two daily soft-gel
caps of the TapouT Premium Omega-3 Fish Oil, resulting in better
health and optimal quality of life!" Dr. Maese further stated, "As
a cardiologist I endorse this top quality nutraceutical, especially
in those with high blood pressure, elevated triglycerides and
hardening of the arteries. The American Heart Association and the
US Institutes of Health recommend, as part of a healthy diet, at
least 1 gram of omega-3 fatty acids a day."
About Axxess Pharma Inc.: Axxess Pharma Inc. is a Nevada
Corporation operating through its wholly owned Canadian Subsidiary:
Axxess Pharma Canada Inc., headquartered in Toronto. Axxess is a specialty Health Care
Products Company dedicated to improving health and quality of life
by offering select medicines, nutritional supplements and over the
counter remedies all across the Americas. Axxess's goal is to bring
additional products to the market and provide new, innovative
options for better health spanning areas such as high cholesterol,
blood pressure, acute pain -- to optimal health management through
improved nutritional supplements. To learn more about our new
products TapouT Extreme Muscle Growth and TapouT Muscle Recovery,
please visit: http://buytapoutme.com and
http://www.tapoutmusclerecovery.com.
About TapouT: TapouT is a lifestyle brand that has been
at the forefront of Mixed Martial Arts since its inception in 1997.
The label is rapidly growing into other sports and categories,
offering merchandise for men, women and kids. TapouT has endorsed
high-profile professional athletes who compete in sports such as
basketball, football, baseball, stock car racing, and most
famously, MMA. TapouT is sold in sporting goods stores,
specialty retailers and online. For updates and more information,
please visit TapouT.com.
https://www.facebook.com/TapouT
https://twitter.com/TapouT
http://www.youtube.com/tapout
Safe Harbor Statement
Statements about the Company's future expectations and all other
statements in this press release other than historical facts, are
"forward-looking statements" within the meaning of Section 27A of
the Securities Act of 1933, Section 21E of the Securities Exchange
Act of 1934, and as that term is defined in the Private Securities
Litigation Reform Act of 1995. The Company intends that such
forward-looking statements be subject to the safe harbors created
thereby.
The above information contains information relating to the
Company that is based on the beliefs of the Company and/or its
management, as well as assumptions made by any information
currently available to the Company or its management. When used in
this document, the words "anticipate," "estimate," "expect,"
"intend," "plans," "projects," and similar expressions, as they
relate to the Company or its management, are intended to identify
forward-looking statements. Such statements reflect the current
view of the Company regarding future events and are subject to
certain risks, uncertainties and assumptions, including the risks
and uncertainties noted. Should one or more of these risks or
uncertainties materialize, or should underlying assumptions prove
to be incorrect, actual results may vary materially from those
described herein as anticipated, believed, estimated, expected,
intended or projected. In each instance, forward-looking
information should be considered in light of the accompanying
meaningful cautionary statements herein. Factors that could cause
results to differ include, but are not limited to, successful
performance of internal plans, the impact of competitive services
and pricing and general economic risks and uncertainties.
Contact:
Investor Relations
Taylor Capitol, Inc.
Stephen Taylor
+1-(973)-351-3868
staylor@TheStockAlerts.com
www.TheStockAlerts.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/axxess-pharma-receives-us-food-and-drug-administration-fda-approval-to-sell-omega-3-fish-oil-muscle-growth-muscle-recovery-supplements-and-turbo-blend-protein-powder-300050750.html
SOURCE Axxess Pharma, Inc